Category Archives: uncategorized

08.17.17

Is There Any Reason to Allow Cigarette Companies to Send Coupons (or Any Other Advertising) to Nonsmokers?

By | Leave a Comment

  A recent study in the Nicotine & Tobacco Research journal confirms that the tobacco industry sends discount cigarette coupons to non-smokers in the USA and that some of those receiving the coupons become smokers. The study concludes that its findings support more restrictive policies to curtail the use of tobacco product discount coupons because […]

Posted in FCTC, FDA, Tobacco, uncategorized ; Tagged: , , , , , , , , , .

08.16.17

Long-Acting Agents for HIV Treatment and Prevention: Updates from the 9th IAS Conference on HIV Science

By | Leave a Comment

The global advocacy for HIV/AIDS has been a model of success for an array of initiatives such as the climate protection movement. Analysts point to the multi-stakeholder composition and the autonomy from governments as some of the features that have allowed for an increasing global consensus on the necessary steps toward scaling up HIV treatment […]

Posted in uncategorized ; Tagged: , , .

08.11.17

Human Rights-Based Approaches to Health: How Do We Measure Them?

By | Leave a Comment

Neil Sircar, J.D., is an LL.M Candidate in Global Health Law at Georgetown University Law Center & the O’Neill Institute for National and Global Health Law. Any questions or comments related to this post can be directed to nrs53@georgetown.edu. Dr. Tedros, the newly-minted Director-General of the World Health Organization, has made human rights and health […]

Posted in uncategorized ; Tagged: .

08.04.17

Reproductive Rights in Flux: Updates from Latin America and the Caribbean

By | Leave a Comment

This post was written by Rebecca Reingold and Priscila Valencia. Despite the tremendous strides made towards the realization of reproductive rights in Latin America and the Caribbean in recent decades, the region remains home to the majority of the world’s most restrictive abortion laws. However, reproductive rights advocates are leading efforts to change that in […]

Posted in Global Health, Human Rights, uncategorized ; Tagged: , , , , , , .

07.27.17

HIV, Racial Justice, and Legal Organizations Release “Consensus Statement on HIV ‘Treatment as Prevention’ in Criminal Law Reform”

By | Leave a Comment

This blog post was authored by Sean Bland and Javier Saladich, a Summer Research Intern at the O’Neill Institute and a third-year law student at ESADE Business and Law School in Barcelona, Spain. Earlier this month, a group of organizations and advocates released a “Consensus Statement on HIV ‘Treatment as Prevention’ in Criminal Law Reform”. […]

Posted in uncategorized ; Tagged: , , .

07.26.17

House Appropriations Committee passes FY2018 health services budget bill that offers no additional funding for HIV or viral hepatitis initiatives; does not acknowledge the rising rates of Hepatitis C infections in the U.S.

By | Leave a Comment

In a vote that followed party lines, the House Appropriations Committee passed the FY2018 Health and Human Services, Education, and Related Agencies Appropriations bill on July 20, 2017. The bill rejects most of the proposed cuts to health services recommended by the current Administration, but does little to boost funding for health services that desperately […]

Posted in Health reform, Healthcare, uncategorized ; Tagged: , , .

07.20.17

Monkey Business: Ebola Research is Benefitted by Recent Discovery

By | Leave a Comment

Rhesus monkey (Image source)   A new study published this week in Nature Microbiology brings good news for research toward the persistence of Ebola virus in asymptomatic individuals. Ebola virus (EBOV) is the virus that causes Ebola (now referred to as Ebola virus disease, or EVD), a viral hemorrhagic fever that has a very high […]

Posted in uncategorized ; Tagged: .

07.07.17

Hepatitis Policy Project Releases Recommendations to Improve Monitoring of the Hepatitis C Epidemic in the U.S.

By | Leave a Comment

The O’Neill Institute for National and Global Health Law’s Hepatitis Policy Project recently released a report offering recommendations to strengthen data collection and monitoring of cases of Hepatitis C in the U.S. in order for public health authorities to gain a better understanding of the effects of the disease and most effective strategies to curb […]

Posted in uncategorized ;

06.02.17

Ebola: Fifteen Years of Silence

By | Leave a Comment

  “The music is not in the notes, but the silence in between.”   – Wolfgang Amadeus Mozart   If one were to describe the history of Ebola outbreaks, one method would be to construct a timeline, with a point on the line for each outbreak.  You could create this timeline with a varying number of […]

Posted in uncategorized ; Tagged: .

05.05.17

Louisiana Proposes that the Federal Government Bypass Patent Restrictions to Acquire Cheaper Hepatitis C Drugs

By | Leave a Comment

Anyone who follows U.S. public health issues – or who reads my blog posts – knows that the cost of the drugs needed to treat Hepatitis C infections is very high. The cost of these drugs is of particular concern to state health authorities who are charged with providing health care for Medicaid recipients and […]

Posted in FDA, Healthcare, uncategorized ; Tagged: .

Stay Informed

Signup for our mailing list and stay up to date on the latest happenings at The O’Neill Institute

Or sign up for our RSS Feed

The views reflected in this blog are those of the individual authors and do not necessarily represent those of the O’Neill Institute for National and Global Health Law or Georgetown University. This blog is solely informational in nature, and not intended as a substitute for competent legal advice from a licensed and retained attorney in your state or country.

See the full disclaimer and terms of use.